AstraZeneca plans independent drug supply chains for US and China
|
As geopolitical tensions threaten to disrupt
pharmaceutical supply chains, AstraZeneca is making plans to manufacture
drugs for the U.S. and China ... |
After Starbucks and McDonald's, Asia's boycotts find a new target
In Indonesia, beauty brands owned by French cosmetics giant L'Oreal are being spurned in favour of Chinese and local alternatives, as the boycotts ... View article...